PubMed

Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?

Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C.

Diabetes Care. 2005 Mar;28(3):600-6.PMID: 15735195 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetic patients with prior specialist care have better glycaemic control than those with prior primary care.

Shah BR, Hux JE, Laupacis A, Mdcm BZ, Austin PC, van Walraven C.

J Eval Clin Pract. 2005 Dec;11(6):568-75.PMID: 16364110 [PubMed - indexed for MEDLINE]Related articles

Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.

Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross-Degnan D.

Diabetes Care. 2007 Apr;30(4):807-12. Epub 2007 Jan 26.PMID: 17259469 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD).

McEwen LN, Bilik D, Johnson SL, Halter JB, Karter AJ, Mangione CM, Subramanian U, Waitzfelder B, Crosson JC, Herman WH.

Diabetes Care. 2009 Jun;32(6):971-6. Epub 2009 Feb 19.PMID: 19228862 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical inertia contributes to poor diabetes control in a primary care setting.

Ziemer DC, Miller CD, Rhee MK, Doyle JP, Watkins C Jr, Cook CB, Gallina DL, El-Kebbi IM, Barnes CS, Dunbar VG, Branch WT Jr, Phillips LS.

Diabetes Educ. 2005 Jul-Aug;31(4):564-71.PMID: 16100332 [PubMed - indexed for MEDLINE]Related articles

Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.

Kennedy L, Herman WH, Strange P, Harris A; GOAL AIC Team.

Diabetes Care. 2006 Jan;29(1):1-8.PMID: 16373887 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycemic response to newly initiated diabetes therapies.

Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed AT, Go AS, Selby JV.

Am J Manag Care. 2007 Nov;13(11):598-606.PMID: 17988185 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between diabetes patients' knowledge about medications and their blood glucose control.

McPherson ML, Smith SW, Powers A, Zuckerman IH.

Res Social Adm Pharm. 2008 Mar;4(1):37-45.PMID: 18342821 [PubMed - indexed for MEDLINE]Related articles

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

Ann Intern Med. 2005 Oct 18;143(8):559-69.PMID: 16230722 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

Cook MN, Girman CJ, Stein PP, Alexander CM, Holman RR.

Diabetes Care. 2005 May;28(5):995-1000.PMID: 15855556 [PubMed - indexed for MEDLINE]Related articlesFree article

How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists.

Grant RW, Wexler DJ, Watson AJ, Lester WT, Cagliero E, Campbell EG, Nathan DM.

Diabetes Care. 2007 Jun;30(6):1448-53. Epub 2007 Mar 2.PMID: 17337497 [PubMed - indexed for MEDLINE]Related articlesFree article

The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study.

Zgibor JC, Songer TJ, Kelsey SF, Weissfeld J, Drash AL, Becker D, Orchard TJ.

Diabetes Care. 2000 Apr;23(4):472-6.PMID: 10857937 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%.

Pani LN, Nathan DM, Grant RW.

Diabetes Care. 2008 Mar;31(3):386-90. Epub 2007 Dec 14.PMID: 18083790 [PubMed - indexed for MEDLINE]Related articlesFree article

Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial.

O'Connor PJ, Sperl-Hillen J, Johnson PE, Rush WA, Crain AL.

Diabetes Care. 2009 Jul;32(7):1158-63. Epub 2009 Apr 14.PMID: 19366977 [PubMed - indexed for MEDLINE]Related articlesFree article

Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study.

MacLean CD, Littenberg B, Kennedy AG.

BMC Fam Pract. 2006 Aug 15;7:50.PMID: 16911789 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk modification for diabetic patients. Are other risk factors treated as diligently as glycemia?

Shah BR, Mamdani M, Jaakkimainen L, Hux JE.

Can J Clin Pharmacol. 2004 Fall;11(2):e239-44. Epub 2004 Nov 10.PMID: 15557673 [PubMed - indexed for MEDLINE]Related articlesFree article

Adequacy of glycemic control in hemodialysis patients with diabetes.

Tascona DJ, Morton AR, Toffelmire EB, Holland DC, Iliescu EA.

Diabetes Care. 2006 Oct;29(10):2247-51.PMID: 17003301 [PubMed - indexed for MEDLINE]Related articlesFree article

An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7.

Phillips LS, Ziemer DC, Doyle JP, Barnes CS, Kolm P, Branch WT, Caudle JM, Cook CB, Dunbar VG, El-Kebbi IM, Gallina DL, Hayes RP, Miller CD, Rhee MK, Thompson DM, Watkins C.

Diabetes Care. 2005 Oct;28(10):2352-60.PMID: 16186262 [PubMed - indexed for MEDLINE]Related articlesFree article

Simulated physician learning intervention to improve safety and quality of diabetes care: a randomized trial.

O'Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Asche SE, Dutta P, Biltz GR.

Diabetes Care. 2009 Apr;32(4):585-90. Epub 2009 Jan 26.PMID: 19171723 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.

Lawrence DB, Ragucci KR, Long LB, Parris BS, Helfer LA.

J Manag Care Pharm. 2006 Jul-Aug;12(6):466-71.PMID: 16925454 [PubMed - indexed for MEDLINE]Related articlesFree article